Insight Molecular Diagnostics Inc. (IMDX) Debt to Equity Ratio
Insight Molecular Diagnostics Inc. (IMDX) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2016-12-31 | 0.05 |
| 2017-12-31 | 0.42 |
| 2018-12-31 | 0.34 |
| 2019-12-31 | 0.08 |
| 2020-12-31 | 0.12 |
| 2021-12-31 | 0.02 |
Debt to equity divides total borrowings by total shareholder equity at the period end. Total borrowings are short-term debt plus long-term debt, including capital lease obligations. Non-debt liabilities such as accounts payable and deferred revenue are excluded. A period is omitted when equity is negative, because the ratio is not meaningful then.
Get Insight Molecular Diagnostics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("IMDX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | IMDX | $4.30 | -1.83% | 0.11M |
| 3 | ||||
| 4 | ||||
| 5 |